Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06388369 |
| Title | Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer (NEPI) |
| Acronym | NEPI |
| Recruitment | Not yet recruiting |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University Hospital, Essen |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |